重症虚血肢治療市場：薬剤別、投与経路別、エンドユーザー別、地域別

重症虚血肢治療の世界市場規模は、2024年に51億米ドルと推定され、2024～2031年のCAGRは8.6％を示し、2031年には91億1,000万米ドルに達すると予測されます。

図.重症虚血肢治療市場シェア（%）、2024年、地域別

世界の重症虚血肢治療市場は、足のような四肢の血液循環が著しく低下する病状を指します。これは、放置すると切断に至ることもある深刻な状態です。この状態は、動脈硬化につながる動脈内の脂肪物質の蓄積によって生じる。血流が制限されるため、四肢に激しい痛みやただれが生じ、それが治癒しないです。世界の重症虚血肢治療市場は、高齢者人口の増加、末梢動脈疾患の症例の増加、利用可能な治療オプションに関する意識の高まりにより、今後数年間で大きく成長する展望です。

市場力学：

世界の重症虚血肢治療市場は、CLIの主要な危険因子である糖尿病の有病率の上昇と世界の高齢者人口の増加によって牽引されています。さらに、先進的な治療機器や薬剤の開発のための研究資金が増加していることも、市場の成長を後押ししています。しかし、血管形成術や血管手術の費用が高いことが、患者の治療へのアクセスを妨げています。CLIに対する意識の高まりと先進国における償還制度の利用可能性は、有利な機会を記載しています。

本調査の主要特徴

• 本レポートでは、世界の重症虚血肢治療市場を詳細に分析し、2023年を基準年とした予測期間（2024～2031年）の市場規模（10億米ドル）と複合年間成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 世界の重症虚血肢治療市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。
• 本レポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• 世界の重症虚血肢治療市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
• 利害関係者は、世界の重症虚血肢治療市場分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• 一貫型機会マップ（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の重症虚血肢治療市場-コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の重症虚血肢治療市場、薬剤別、2019～2031年（10億米ドル）

• イントロダクション
• 降圧剤
• 抗血小板薬
• 抗血栓剤
• 脂質低下剤
• その他

第6章 世界の重症虚血肢治療市場、投与経路別、2019～2031年（10億米ドル）

• イントロダクション
• 経口
• 母子間

第7章 世界の重症虚血肢治療市場、エンドユーザー別、2019～2031年（10億米ドル）

• イントロダクション
• 病院
• 専門クリニック
• 外来手術センター
• 高齢者ホーム
• その他

第8章 世界の重症虚血肢治療市場、地域別、2019～2031年（10億米ドル）

• イントロダクション
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東

第9章 競合情勢

• 企業プロファイル
  • Advanced Brain Monitoring, Inc.
  • Medtronic plc
  • fic Corporation
  • Abbott Laboratories
  • Cook Medical Inc.
  • Cardiovascular Systems, Inc.
  • Philips Healthcare
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Biotronik SE &Co. KG
  • Cordis Corporation
  • Smith &Nephew plc
  • Stryker Corporation
  • AngioDynamics, Inc.
  • GE Healthcare
  • Sanofi SA
  • AstraZeneca plc
  • Bristol-Myers Squibb Company

第10章 アナリストの推奨事項

• 隆盛と衰退
• 一貫型機会マップ

第11章 参考文献と調査手法

• 参考文献
• 調査手法

The global critical limb ischemia treatment market is estimated to be valued at USD 5.10 Bn in 2024 and is expected to reach USD 9.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Figure. Critical Limb Ischemia Treatment Market Share (%), By Region 2024

Global critical limb ischemia treatment market refers to the medical condition where the blood circulation to extremities like legs is severely reduced. This is a serious condition that can lead to amputation if left untreated. The condition arises due to the accumulation of fatty substances in arteries leading to atherosclerosis. The limited blood flow leads to severe pain and sores on extremities which do not heal. The global critical limb ischemia treatment market is poised to grow significantly in the coming years due to increasing geriatric population, rising cases of peripheral artery diseases, and growing awareness regarding available treatment options.

Market Dynamics:

The global critical limb ischemia treatment market is driven by the rising prevalence of diabetes and growing geriatric population globally which are major risk factors for CLI. Additionally, increasing research funding for the development of advanced treatment devices and drugs is also boosting the market growth. However, high cost of angioplasty and vascular surgeries hampers patient's accessibility to treatment. Growing awareness about CLI and availability of reimbursement coverage in developed nations provides lucrative opportunities.

Key Features of the Study:

• This report provides in-depth analysis of the global critical limb ischemia treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global critical limb ischemia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic, Boston Scientific, Cardinal Health, Terumo, Abbott Laboratories, etc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global critical limb ischemia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global critical limb ischemia treatment market

Detailed Segmentation-

• By Drugs
  • Antihypertensive Agents
  • Antiplatelet Drugs
  • Antithrombotic Agents
  • Lipid-lowering Agents
  • Others
• By Route of administration
  • Oral
  • Parentral
  • Others
• By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
  • Nursing Homes
  • Others (Rehabilitation Centers, etc.)
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Cook Medical Inc.
  • Cardiovascular Systems, Inc.
  • Philips Healthcare
  • Braun Melsungen AG
  • Terumo Corporation
  • Biotronik SE & Co. KG
  • Cordis Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • AngioDynamics, Inc.
  • GE Healthcare
  • Sanofi S.A.
  • AstraZeneca plc
  • Bristol-Myers Squibb Company

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drugs
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Critical Limb Ischemia Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Critical Limb Ischemia Treatment Market, By Drugs, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Antihypertensive Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Antiplatelet Drugs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Antithrombotic Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Lipid-lowering Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Critical Limb Ischemia Treatment Market, By Route of Administration 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Parentral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Critical Limb Ischemia Treatment Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ambulatory Surgery Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Nursing Homes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Critical Limb Ischemia Treatment Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Advanced Brain Monitoring, Inc.
    • Company Highlights
    • Drugs Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic plc
    • Boston Scienti Company Highlights
    • Drugs Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • fic Corporation
    • Company Highlights
    • Drugs Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott Laboratories
    • Company Highlights
    • Drugs Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cook Medical Inc.
    • Company Highlights
    • Drugs Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cardiovascular Systems, Inc.
    • Company Highlights
    • Drugs Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Philips Healthcare
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Biotronik SE & Co. KG
  • Cordis Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • AngioDynamics, Inc.
  • GE Healthcare
  • Sanofi S.A.
  • AstraZeneca plc
  • Bristol-Myers Squibb Company

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. Reference and Research Methodology

• References
• Research Methodology
• About us and Sales Contact